In looking at today's buyout of another biotec we could be in the running for an offer. Many large pharma's are
hurting for pipeline additions and we certainly have an approved successful drug and a promising pipeline.
Textbook buy and hold in here.
depends on your thinking. SNTS was bought out at about 6.5 times sales, VPHM was bought out at almost 8 times sales. I think Nader would be waiting to get sales to around 500 Million before he started talking to suitors - another year or so. the potential upside is the MC of BMRN which has $500 million sales and a market cap of over 8 billion, wouldn't that be nice?